Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Biocon Ltd rises for third consecutive session     Back
(24 Apr 2024)

Biocon Ltd gained for a third straight session today. The stock is quoting at Rs 292.9, up 4.55% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.37% on the day, quoting at 22450.85. The Sensex is at 74033.44, up 0.4%. Biocon Ltd has risen around 13.66% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 1.06% in last one month and is currently quoting at 18463.75, up 0.79% on the day. The volume in the stock stood at 191.55 lakh shares today, compared to the daily average of 59.25 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 293.45, up 4.78% on the day. Biocon Ltd is up 26.85% in last one year as compared to a 26.35% spurt in NIFTY and a 49.4% spurt in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 23.

Top